Loading...

Global Wellness And Digital Rollout Will Extend Market Leadership

Published
02 Sep 24
Updated
30 Apr 26
Views
441
30 Apr
US$515.04
AnalystConsensusTarget's Fair Value
US$681.50
24.4% undervalued intrinsic discount
Loading
1Y
26.5%
7D
7.3%

Author's Valuation

US$681.524.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 30 Apr 26

Fair value Increased 1.19%

ULTA: Unleashed Plan And AI Personalization Will Support Bullish Outlook

Ulta Beauty's analyst price target has been updated modestly higher, with fair value moving from about $673.50 to $681.50 as analysts factor in slightly adjusted growth, margin, and P/E assumptions following a mix of target raises and trims tied to recent earnings, guidance, and views on the "Unleashed" growth plan.

Analyst Commentary

Street research around Ulta Beauty is mixed, with many firms still positive on the long term setup while trimming price targets after recent quarterly results and guidance. The comments cluster into two broad camps that focus on execution of the "Unleashed" plan, earnings visibility, and how current trading levels line up with perceived fair value.

Bullish Takeaways

  • Bullish analysts highlight Ulta's ability to gain or regain share, pointing to positive beauty category trends, successful product launches, and interest in how the company is performing across both mass and prestige beauty as key supports for the growth case.
  • Several bullish analysts frame the "Unleashed" strategy and growth initiatives, including international expansion and loyalty plus infrastructure capabilities, as important levers for longer term earnings power even as near term assumptions are recalibrated.
  • Pre earnings research referenced improving margins and raised Q4 EPS estimates, with some commentary that Ulta is leveraging prior investments, which feeds into higher price targets and supports the view that current valuation can be underpinned by execution.
  • JPMorgan, while cutting its target, characterizes the outlook as conservative and notes that quarter to date comparable sales were running above its 4% estimate, using the post earnings pullback as a basis to argue that the risk reward skew is still attractive.

Bearish Takeaways

  • Bearish analysts focus on the most recent quarter coming in short of more elevated expectations, especially on comparable sales and margin, which feeds into reduced targets and concerns that prior assumptions on growth and profitability were too optimistic.
  • Commentary around SG&A includes references to deleverage and the need for better visibility on "normalizing" spending, which introduces uncertainty around how much of Ulta's operating margin profile can be sustained and what that implies for valuation multiples.
  • Some research describes the setup for 2026 as more challenging, with issues cited on both comparable sales and margin that could, in their view, bring the shares closer to historical valuation norms rather than supporting prior peak multiples.
  • Wells Fargo's Underweight stance underscores a more cautious camp that sees the recent results and guidance as a check on the prior bullish case, and uses that to justify a lower fair value range versus peers who still see upside tied to execution of growth initiatives.

What's in the News

  • Ulta Beauty CEO discussed how GLP 1 medications are influencing guest demand for certain products, highlighting shifting beauty and wellness needs tied to weight management trends (Periodical, Bloomberg Intelligence).
  • Ulta Beauty and Google introduced two Gemini enabled AI tools that give guests personalized product recommendations and checkout inside Google Search and the Gemini app, while Ulta AI on Ulta's own platforms uses insights from more than 46 million members to guide product discovery and recommendations (Key Developments).
  • Cymbiotika entered Ulta Beauty's Wellness assortment, with products focused on areas such as collagen support, sleep, and healthy aging, including an NAD+ product that is exclusive to Ulta at launch and supported by education, influencer campaigns, and loyalty programs (Key Developments).
  • Therabody expanded its presence in Ulta Beauty to more than 1,000 stores, adding wellness and skincare devices like TheraFace tools and bringing Theragun Relief in store for the first time, with availability in stores and on Ulta.com starting the week of March 29, 2026 (Key Developments).
  • K Beauty World broadened its lineup on Ulta Beauty Marketplace, adding 17 Korean beauty brands across skincare, hair care, body care, and color cosmetics, with strong marketplace performers such as Dr. Melaxin moving into all 1,500 Ulta stores after repeated online sellouts (Key Developments).

Valuation Changes

  • Fair Value: Updated modestly higher from $673.50 to $681.50, reflecting a small upward adjustment in the overall valuation range.
  • Discount Rate: Adjusted slightly from 8.51% to about 8.58%, implying a marginally higher required return in the model.
  • Revenue Growth: Ticked up from roughly 5.84% to about 5.85%, indicating a very small change in top line growth assumptions.
  • Net Profit Margin: Trimmed from about 9.55% to roughly 9.52%, a small reduction in expected profitability on future dollar revenue.
  • Future P/E: Moved from about 24.5x to roughly 24.9x, indicating a slightly higher multiple applied to future earnings in the updated framework.
16 viewsusers have viewed this narrative update

Key Takeaways

  • Wellness category expansion, exclusive partnerships, and curated marketplace enhance brand appeal to younger demographics and support stronger revenue growth and margins.
  • Digital investments, loyalty program strength, and global expansion strategies boost customer retention, repeat purchases, and create diversified pathways for long-term profitability.
  • Rising costs, increased competition, and key partnership losses threaten Ulta's margins, store viability, and long-term growth as it navigates digital shifts and international expansion initiatives.

Catalysts

About Ulta Beauty
    Operates as a specialty beauty retailer in the United States.
What are the underlying business or industry changes driving this perspective?
  • Ulta Beauty's expansion into the wellness category, with dedicated in-store footprints and over 150 brands, is set to capture a larger share of the rapidly growing self-care and wellness market, driving new customer acquisition and top-line revenue growth over the long term.
  • The widening of Ulta's assortment-particularly through exclusive brand launches, key partnerships with in-demand emerging brands, and the rollout of a curated online marketplace-positions the company to attract Gen Z and Millennials, increase basket sizes, and capture higher-margin sales, benefiting both revenue and gross margins.
  • Enhanced investment in digital infrastructure, including new personalization and automation tools, as well as omnichannel fulfillment with half of e-commerce orders being fulfilled by stores, supports increased e-commerce penetration and customer retention, directly driving growth in revenue and improved operating leverage.
  • Record loyalty membership (now 45.8 million) and continued strong program engagement, together with omnichannel strategies and brand differentiation, lay the foundation for sustainable increases in repeat purchase rates and customer lifetime value, positively impacting revenue consistency and resilient earnings.
  • International expansion via Space NK acquisition (UK/Ireland), entry into Mexico, and planned debut in the Middle East allows Ulta to tap into new, underpenetrated geographies with strong beauty markets, creating additional long-term revenue streams and potential operating profit growth as the international business scales.
Ulta Beauty Earnings and Revenue Growth

Ulta Beauty Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Ulta Beauty's revenue will grow by 5.8% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 9.3% today to 9.5% in 3 years time.
  • Analysts expect earnings to reach $1.4 billion (and earnings per share of $34.64) by about April 2029, up from $1.2 billion today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 25.1x on those 2029 earnings, up from 20.0x today. This future PE is greater than the current PE for the US Specialty Retail industry at 19.9x.
  • Analysts expect the number of shares outstanding to decline by 2.69% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.58%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • The shift towards e-commerce, while presenting growth opportunities, also increases pressure on Ulta's physical retail footprint-highlighted by rising store payroll, rent, insurance, and CAM costs. Sustaining the large number of stores amid increasing online competition and consumer migration to digital channels may compress both sales growth and net margins in the long run.
  • Ulta's ongoing need for strategic investments-such as international expansion (Space NK in the UK, entry into Mexico and the Middle East), digital and supply chain upgrades, and new store remodels-is driving elevated SG&A expenses. If these investments underperform or if overseas markets prove less lucrative, operating costs could rise faster than revenue, further pressuring long-term earnings.
  • Wage inflation and higher employee benefit costs (particularly healthcare) are repeatedly cited as challenges. These structural cost increases, combined with more selling hours to support in-store experience, may steadily erode operating margin and net income despite top-line growth.
  • The looming loss of the Target shop-in-shop partnership in 2026 removes a high-margin revenue stream (with 60–65% flow-through to EBIT), and despite management's optimism, there is no guarantee that current initiatives will fully offset this loss, raising risk to operating profit and overall earnings quality.
  • The competitive intensity of the beauty retail market-including increased focus on wellness/"skinvestment," expansion by premium and indie brands, and direct-to-consumer strategies by major labels-raises the risk that Ulta may struggle to adapt its product assortment and digital offerings quickly enough, potentially impairing revenue growth and customer loyalty over the long term.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $681.5 for Ulta Beauty based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $810.0, and the most bearish reporting a price target of just $475.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $14.7 billion, earnings will come to $1.4 billion, and it would be trading on a PE ratio of 25.1x, assuming you use a discount rate of 8.6%.
  • Given the current share price of $530.23, the analyst price target of $681.5 is 22.2% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Ulta Beauty?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

US$427.41
FV
20.5% overvalued intrinsic discount
4.50%
Revenue growth p.a.
124
users have viewed this narrative
2users have liked this narrative
0users have commented on this narrative
3users have followed this narrative